Skip to main content
Themis Medicare Ltd. logo

Themis Medicare Ltd. — Investor Relations & Filings

Ticker · THEMISMED ISIN · INE083B01024 LEI · 335800LHRDVIKH69AF42 BSE.NS Manufacturing
Open in API
Filings indexed 706 across all filing types
Latest filing 2025-09-12 Board/Management Inform…
Country IN India
Listing BSE.NS THEMISMED

About Themis Medicare Ltd.

https://www.themismedicare.com/

Themis Medicare Ltd. is a research-driven pharmaceutical organization specializing in the development, manufacture, and marketing of a diverse range of therapeutic products. The company focuses on high-value segments including pain management, anesthesia, critical care, anti-infectives, and oncology. Its core competencies lie in the production of Active Pharmaceutical Ingredients (APIs) and complex finished dosage formulations, particularly injectables. Themis Medicare maintains a strong emphasis on Research and Development, operating state-of-the-art facilities that adhere to international quality standards such as WHO-GMP. Through strategic partnerships and a robust supply chain, the company serves both domestic and international markets, providing specialized medical solutions for hospital-based care and chronic disease management. Its portfolio includes proprietary delivery systems and differentiated generic products designed to improve patient outcomes.

Recent filings

Filing Released Lang Actions
General Updates
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) disclosing information pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It announces the approval of a dividend for the financial year ended 31 March 2025, appointment of a secretarial auditor, and appointment of an independent woman director. The document includes detailed disclosures about the director's appointment as required by SEBI regulations. There are no financial statements or detailed financial performance data present. The document is an announcement of corporate actions and disclosures rather than a full report or financial filing. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2025-09-12 English
Shareholders meeting
Regulatory Filings
2025-09-12 English
Shareholders meeting
AGM Information Classification · 95% confidence The document is titled 'Proceedings of the 55th Annual General Meeting of Themis Medicare Limited' and details the events and discussions held during the AGM on 12th September 2025. It includes information about attendance, quorum, agenda items such as adoption of financial statements, director appointments, dividend declarations, and other business matters. It also mentions voting procedures and outcomes. The document is a summary or gist of the AGM proceedings rather than the full Annual Report or financial statements themselves. It is not a voting results declaration (DVA) since it includes more comprehensive meeting details, nor is it a proxy solicitation or presentation. The length (7709 characters) and content indicate it is a detailed meeting proceedings document. Therefore, the appropriate classification is AGM Information (AGM-R).
2025-09-12 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding a newspaper publication titled 'Notice with respect to Special Window for re-lodgement of transfer requests of physical shares'. It includes details about the publication and its availability on the company's website. The content is an announcement informing shareholders and the exchanges about the notice and the special window for re-lodgement of transfer requests. There are no financial statements, management discussion, or detailed financial data. The document is relatively short and serves as an announcement of a notice rather than the notice itself or a detailed report. Therefore, it fits best as a Regulatory Filing (RNS), which is a general regulatory announcement that does not fit into other specific categories.
2025-09-10 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document contains multiple notices and announcements related to Annual General Meetings (AGMs) of different companies, including detailed information about the notice of the 55th AGM of Themis Medicare Limited and the 30th AGM of Shree Ganesh Remedies Limited. It includes information about remote e-voting, voting rights, and the dispatch of the Annual Report along with the Notice of AGM. The document also includes newspaper advertisement copies for intimation of the AGM notice as per SEBI Listing Regulations. There is no detailed financial data or full financial statements present, nor is this a transcript or a management discussion. The primary focus is on the notice and related voting information for the AGM, which fits the category of AGM Information (AGM-R). The document length is substantial and contains detailed AGM-related information, not just a brief announcement or a report publication announcement. Therefore, the classification is AGM Information (AGM-R) with high confidence.
2025-08-19 English
Shareholders meeting
Regulatory Filings
2025-08-18 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.